
doi: 10.1021/cb500977q
pmid: 25554827
There is growing interest in aldehyde dehydrogenases (ALDHs) because of their overexpression in cancer stem cells and the ability to mediate resistance to cancer drugs. Here, we report the first crystal structure of an aldehyde dehydrogenase complexed with the inhibitor 4-diethylaminobenzaldehyde (DEAB). Contrary to the widely held belief that DEAB is a reversible inhibitor of ALDHs, we show that DEAB irreversibly inactivates ALDH7A1 via formation of a stable, covalent acyl-enzyme species.
Models, Molecular, Binding Sites, Hydrogen Bonding, Aldehyde Dehydrogenase, Crystallography, X-Ray, NAD, Protein Structure, Secondary, Protein Structure, Tertiary, Benzaldehydes, Drug Discovery, Humans, Enzyme Inhibitors, Protein Binding
Models, Molecular, Binding Sites, Hydrogen Bonding, Aldehyde Dehydrogenase, Crystallography, X-Ray, NAD, Protein Structure, Secondary, Protein Structure, Tertiary, Benzaldehydes, Drug Discovery, Humans, Enzyme Inhibitors, Protein Binding
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 35 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
